Back to search

Canada· CA-DIN-02518201

RED EYE TRIPLE ACTION

A tetryzolin, kombinationen product containing polyethylene glycol 400 + tetrahydrozoline hydrochloride, registered in Canada by JOHNSON & JOHNSON INC. The same ATC class is registered in 6 of our 19 countries.

ATC S01GA52

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedRED EYE TRIPLE ACTIONATCS01GA52REGISTER NO.CA-DIN-02518201PACKS LISTED0CHECKEDOctober 1, 2026

Where it is registered

Tetryzolin, kombinationen is registered in 6 of 19 countries.

Countries holding a registration under ATC S01GA52 (tetryzolin, kombinationen), each read from that country’s own register.

  • This record: Canada, from Health Canada Drug Product Database (Canada)
  • 5 of them publish a price we can compare per daily dose

Tetryzolin, kombinationen · ATC S01GA52

6 / 19 countries

  • Canada
  • Czechiaprice
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
POLYETHYLENE GLYCOL 400 + TETRAHYDROZOLINE HYDROCHLORIDE
Manufacturer
JOHNSON & JOHNSON INC
Country
Canada (CA)
ATC code
S01GA52
ATC class
Tetryzolin, Kombinationen
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Tetryzolin, kombinationen in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tetryzolin, kombinationen products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/6c35d162-8ece-407f-9bfc-c865523052bc
GET /v1/drugs/6c35d162-8ece-407f-9bfc-c865523052bc?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02518201",
  "form": "DROPS",
  "class": "Human",
  "routes": [
    "OPHTHALMIC"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "S01GA52",
  "schedule": [
    "OTC"
  ],
  "drug_code": "100752",
  "strengths": [
    "1 %",
    "0.05 %"
  ],
  "ahfs_class": null,
  "substances": [
    "POLYETHYLENE GLYCOL 400",
    "TETRAHYDROZOLINE HYDROCHLORIDE"
  ],
  "product_categorization": null
}

See everything about tetryzolin, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.